NASOEASE ALLERGY (AUBEX PHARMA Pty Ltd)
Product name
NASOEASE ALLERGY
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
181 (255 working days)
Active ingredients
mometasone furoate monohydrate
Registration type
New generic medicine
Indication
For the prophylaxis or treatment of allergic rhinitis for up to six months in adults and children 12 years of age and over